Page 358 - EMF–Elektromagnetische Felder
P. 358

80 81
84 85 86 87
2017, S. 2311–2313; DOI: 10.1056/NEJMp1611928.
Shin, T. G., Kim, Y. J., Ryoo, S. M., Hwang, S. Y., Jo, I. J., Chung, S. P., Choi, S. H., Suh, G. J., Kim, W. Y.: »Early Vitamin C and Thiamine Administration to Patients with Septic Shock in Emergency Departments: Propensity Score-Based Analysis of a Before-and-After Cohort Study« in: Journal of Clinical Medicine, Vol. 8, Nr. 1, 16. Januar 2019, E102; DOI: 10.3390/jcm8010102.
Balakrishnan, M., Gandhi, H., Shah, K., Pandya, H., Patel, R., Keshwani, S., Yadav, N.: »Hydrocortisone, Vitamin C and Thiamine for the Treatment of Sepsis and Septic Shock Following Cardiac Surgery« in: Indian Journal of Anaesthesia, Vol. 62, Nr. 12, Dezember 2018, S. 934-939; DOI: 10.4103/ija. IJA_361_18.
Marik, P. E.: »Hydrocortisone, Ascorbic Acid and Thiamine (HAT Therapy) for the Treatment of Sepsis. Focus on Ascorbic Acid« in: Nutrients, Vol. 10, Nr. 11, 14. November 2018, E1762; DOI: 10.3390/nu10111762.
Moskowitz, A., Andersen, L. W., Huang, D. T., Berg, K. M., Grossestreuer, A. V., Marik, P. E., Sherwin, R. L., Hou, P. C., Becker, L. B., Cocchi, M. N., Doshi, P., Gong, J., Sen, A., Donnino. M. W.: »Ascorbic Acid, Corticosteroids, and Thiamine in Sepsis: A Review of the Biologic Rationale and the Present State of Clinical Evaluation« in: Critical Care, Vol. 22, Nr. 1, 29. Oktober 2018, S. 283; DOI: 10.1186/s13054-018-2217-4.
Surh Y. J., Kundu, J. K., Na, H. K.: »Nrf2 as a Master Redox Switch in Turningon the Cellular Signaling Involved in the Induction of Cytoprotective Genes by Some Chemopreventive Phytochemicals« in: Planta Medica, Vol. 74, Nr. 13, Oktober 2008, S. 1526–1539.
Nakagawa, F., Morino, K., Ugi, S., Ishikado, A., Kondo, K., Sato, D., Konno, S., Nemoto, K., Kusunoki, C., Sekine, O., Sunagawa, A., Kawamura, M., Inoue, N., Nishio, Y., Maegawa, H.: »4-Hydroxy Hexenal Derived from Dietary n-3 Polyunsaturated Fatty Acids Induces Anti-Oxidative Enzyme Heme Oxygenase-1 in Multiple Organs« in: Biochemical and Biophysical Research Communications, Vol. 443, Nr. 3, 2014, S. 991–996.
Kumar, H., Kim, I. S., More, S. V., Kim, B. W., Choi, D. K.: »Natural Product- Derived Pharmacological Modulators of Nrf2/ARE Pathway for Chronic Diseases« in: Natural Products Reports, Vol. 31, Nr. 1, Januar 2014, S. 109–139.
Lewis, K. N., Mele, J., Hayes, J. D., Buffenstein, R.: »Nrf2, a Guardian of Healthspan and Gatekeeper of Species Longevity« in: Integrative and Comparative Biology, Vol. 50, Nr. 5, November 2010, S. 829–843.
Kapeta, S., Chondrogianni, N., Gonos, E. S.: »Nuclear Erythroid Factor 2-Mediated Proteasome Activation Delays Senescence in Human Fibroblasts« in: Journal of Biological Chemistry, Vol. 285, Nr. 11, 12. März 2010, S. 8171–8184.
Jódar, L., Mercken, E. M., Ariza, J., Younts, C., González-Reyes, J. A., Alcaín, F. J., Burón, I., de Cabo, R., Villalba, J. M.: »Genetic Deletion of Nrf2 Promotes

   356   357   358   359   360